In its quest to split into three publicly traded companies, Bausch Health has filed to make an initial public offering of common shares in the U.S. and most of Canada for its wholly owned subsidiary Bausch + Lomb Corporation. Specifically, it has filed a Registration Statement with the U.S. Securities ...
Already an Eyewear Intelligence subscriber? Sign in here.
Buying a membership today will give you:
Or sign-up for a trial month for just 9,90€. To continue reading this article register now.